The Drug Franchising Didn't See Coming

By Tam Goldsmith

GLP-1 drugs may reshape consumer spending, creating new opportunities for franchise brands aligned with health and wellness.

Ozempic may not just change how consumers eat. It may change where they spend.

For most of the past decade, the franchise industry has been obsessed with technology.

Operators have invested heavily in mobile ordering, loyalty programmes, delivery platforms, artificial intelligence, automation, customer data systems, and digital engagement tools. Conference stages have been dominated by discussions about innovation, disruption, and the technologies most likely to shape consumer behaviour in the years ahead.

Those conversations matter. Technology has fundamentally changed how consumers discover brands, place orders, and interact with businesses.

But what if the biggest change to consumer spending habits isn't coming from technology at all?

What if it is coming from healthcare?

Across the United States, millions of consumers are now taking GLP-1 medications such as Ozempic, Wegovy, and Zepbound. Most of the attention has understandably focused on weight loss and healthcare outcomes. Pharmaceutical companies have benefited. Investors have paid attention. Healthcare providers have adapted.

What few industries have fully considered is what happens next.

Because once consumers start changing how much they eat, how often they eat, and how they think about food, the consequences extend far beyond healthcare.

They begin to affect spending.

Consider something as simple as breakfast.

For years, millions of consumers have followed remarkably similar routines. A coffee on the way to work. A breakfast sandwich picked up out of habit. A snack for later in the morning. None of those purchases feel particularly significant on their own, but together they represent billions of dollars in annual spending and form part of the economic foundation of countless franchise businesses.

Now imagine a consumer who still buys the coffee but skips the breakfast because they simply are not hungry.

Nothing dramatic has happened. There is no boycott, no economic downturn, and no conscious decision to spend less. One small habit has simply disappeared.

That may not sound important.

At scale, it becomes extremely important.

Franchising has always been built on repeated consumer behaviour. The industry does not rely on one customer making one large purchase. It relies on millions of customers making small purchases over and over again. When those behaviours change, even slightly, entire sectors can feel the impact.

This is where the conversation becomes far more interesting than food.

The immediate assumption is that if consumers eat less, restaurants lose. That may be partially true, but history suggests consumer spending rarely disappears altogether. It usually moves somewhere else.

Someone who becomes more intentional about food often starts paying closer attention to other aspects of their wellbeing. Weight management frequently leads to conversations about nutrition. Nutrition leads to fitness. Fitness often leads to recovery, hydration, preventative healthcare, sleep quality, and longevity.

What begins as a prescription can eventually evolve into a broader lifestyle shift.

That possibility should interest franchise operators far beyond the restaurant sector.

Businesses positioned around wellness, recovery, preventative health, hydration, and performance optimisation may be benefiting from the same behavioural change that GLP-1 drugs are accelerating. Brands such as Restore Hyper Wellness, Prime IV Hydration, Pure Green, and Gameday Men's Health are not selling less consumption. They are selling better outcomes.

That distinction may become increasingly important.

For decades, many franchise categories benefited from abundance. Larger portions, greater convenience, constant accessibility, and immediate gratification became powerful drivers of growth. Consumers rewarded businesses that helped them consume more easily and more frequently.

The emerging wellness economy works differently.

Consumers are increasingly spending money to improve how they feel, how they perform, and how they age. They are becoming more focused on outcomes and less focused on indulgence. That does not mean restaurants disappear or consumers stop enjoying convenience. It means priorities begin to shift.

The controversial part is that the franchise industry may be paying attention to the wrong disruption.

Artificial intelligence will undoubtedly improve operations. Automation will reduce costs. Technology will continue reshaping customer engagement. But technology typically changes how consumers buy.

Behavioural shifts change why they buy.

Historically, the biggest opportunities in franchising have emerged when operators recognised changing consumer priorities before they became obvious. Fast-casual brands recognised that consumers wanted something different from traditional quick service. Boutique fitness brands recognised growing demand for specialised wellness experiences. Home-service operators benefited from rising demand for convenience.

The winners were not necessarily the businesses with the best technology.

They were the businesses that understood people.

That is why GLP-1 medications matter.

Not because they are a healthcare story.

Because they are becoming a consumer behaviour story.

And consumer behaviour has always been one of the most powerful forces in franchising.

The optimistic view is that this creates opportunity rather than threat. Consumer priorities are constantly evolving, and franchising has repeatedly shown an ability to adapt. The brands that thrive over the next decade will likely be those that understand where spending is moving rather than focusing solely on where it has traditionally been.

The deeper lesson from Ozempic may have very little to do with weight loss.

It may be that millions of consumers are quietly changing their relationship with consumption itself.

And if that happens, the effects could reach far beyond healthcare and reshape parts of the franchise economy in ways few operators currently expect.

What We Can Learn From This

GLP-1 medications are creating more than a healthcare story. They are creating a consumer behaviour story. Operators should pay close attention to how changing attitudes toward nutrition, health, recovery, and wellbeing may redirect spending across multiple franchise categories. The strongest future franchise systems will likely align with the outcomes consumers increasingly value rather than relying on historical spending habits. Franchising has always adapted to behavioural change, and the wellness economy may be one of its next major growth engines.